✦ LIBER ✦

Can Patients' Likelihood of Benefiting from Primary Chemotherapy for Breast Cancer Be Predicted Before Commencement of Treatment?

✍ Scribed by Keith N. Ogston; Iain D. Miller; Andrew C. Schofield; Andreas Spyrantis; Eleni Pavlidou; Tarun K. Sarkar; Andrew W. Hutcheon; Simon Payne; Steven D. Heys

Book ID: 111575089
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 100 KB
Volume: 86
Category: Article
ISSN: 0167-6806
DOI: 10.1023/b:brea.0000032986.00879.d7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Which patients benefit most from primary

Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial

✍ van Meurs, Hannah S.; Tajik, Parvin; Hof, Michel H.P.; Vergote, Ignace; Kenter, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 712 KB